See for the latest information about COVID-19 vaccinations in Canterbury.
View our COVID-19 page for general advice, where to get COVID-19 tests, and visiting guidelines for our hospital services.

Stem cell transplants

1 document.

Autologous haematopoietic stem cell transplants (aHSCT) available to patients

Multiple Sclerosis New Zealand is aware that your DHB has been presented with a Business Case to make autologous haematopoietic stem cell transplants (aHSCT) available in your DHB to patients with Multiple Sclerosis. Multiple Sclerosis New Zealand requests a copy of this Business Case along with further information including any analysis of the business case correspondence etc regarding your decisions on this application.


More informationDownload pdf (100KB)

Showing 1-1 of 1 results, page 1 of 1.

Page last updated: 23 June 2021

Is this page useful?